Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways

Abstract

We evaluated the ability of neonatal porcine islets to engraft and restore glucose control in pancreatectomized rhesus macaques. Although porcine islets transplanted into nonimmunosuppressed macaques were rapidly rejected by a process consistent with cellular rejection, recipients treated with a CD28-CD154 costimulation blockade regimen achieved sustained insulin independence (median survival, >140 days) without evidence of porcine endogenous retrovirus dissemination. Thus, neonatal porcine islets represent a promising solution to the crucial supply problem in clinical islet transplantation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Assessment of neonatal porcine islet xenograft function in pancreatectomized rhesus macaques.
Figure 2: Immunohistochemical assessment of neonatal porcine islet xenografts and viral monitoring in transplant recipients.

Similar content being viewed by others

References

  1. Korbutt, G.S. et al. J. Clin. Invest. 97, 2119–2129 (1996).

    Article  CAS  Google Scholar 

  2. Trivedi, N. et al. Endocrinology 142, 2115–2122 (2001).

    Article  CAS  Google Scholar 

  3. Kin, T. et al. Diabetes 54, 1032–1039 (2005).

    Article  CAS  Google Scholar 

  4. Ye, Y. et al. Transplantation 58, 330–337 (1994).

    Article  CAS  Google Scholar 

  5. Lin, S.S. et al. Transplantation 70, 1667–1674 (2000).

    Article  CAS  Google Scholar 

  6. Kirchhof, N. et al. Xenotransplantation 11, 396–407 (2004).

    Article  Google Scholar 

  7. Galili, U. et al. Immunol. Today 14, 480–482 (1993).

    Article  CAS  Google Scholar 

  8. Chen, G. et al. Nat. Med. 11, 1295–1298 (2005).

    Article  CAS  Google Scholar 

  9. Adams, A.B. et al. J. Immunol. 174, 542–550 (2005).

    Article  CAS  Google Scholar 

  10. Adams, A.B. et al. Diabetes 51, 265–270 (2002).

    Article  CAS  Google Scholar 

  11. Adams, A.B. et al. J. Immunol. 167, 1103–1111 (2001).

    Article  CAS  Google Scholar 

  12. Kawai, T. et al. Nat. Med. 6, 114 (2000).

    Article  CAS  Google Scholar 

  13. Collins, B.H. et al. J. Immunol. 154, 5500–5510 (1995).

    CAS  PubMed  Google Scholar 

  14. Oriol, R. et al. Transplantation 56, 1433–1442 (1993).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Juvenile Diabetes Research Foundation Center Grant 6-2005-1328, and the US National Institutes of Health grant U19-AI51731 with additional support from the Yerkes Base Grant P51-RR000165-45, the McKelvey Lung Transplant Center, and the Carlos and Marguerite Mason Trust as support for C.P.L. In addition, R.V.R. was supported by the Canadian Institutes of Health Research grant FRN-8030, Edmonton Civic Employees Charitable Assistance Fund, Alberta Diabetes Foundation, and University Hospital Foundation MacLachlan Fund. G.S.K. received a Career Development Award from the JDRF and a Senior Scholarship from the Alberta Heritage Foundation for Medical Research. We are indebted to the Yerkes veterinary staff, in particular, D. Anderson, R. Fest and M. Hossfield, for their support. We also thank K. Kite-Powell for editorial comments. Belatacept and H106 (CD154-specific antibody) for these studies were provided by Bristol-Myers Squibb.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ray V Rajotte or Christian P Larsen.

Ethics declarations

Competing interests

Christian P. Larsen and Thomas C. Pearson have received consulting fees from Bristol-Myers Squibb, Pfizer and Abbott and grant support from Bristol-Myers Squibb, Novartis and Abegenix and have assigned all future royalties relating to US patent 5,916,560, “Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith,” issued jointly to Bristol-Myers Squibb and Emory University, to Emory University.

Supplementary information

Supplementary Fig. 1

Experimental scheme of transplant experiments. (PDF 37 kb)

Supplementary Fig. 2

Assessment of anti-Gal and total anti-pig IgG. (PDF 52 kb)

Supplementary Table 1

Cohorts, survival, and characterization of neonatal porcine islets. (PDF 27 kb)

Supplementary Methods (PDF 94 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cardona, K., Korbutt, G., Milas, Z. et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 12, 304–306 (2006). https://doi.org/10.1038/nm1375

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1375

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing